Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2005
10/20/2005CA2561952A1 Use of 5,10-methylene tetrahydrofolate for the treatment of cancer
10/20/2005CA2561947A1 Preventives/remedies for cancer
10/20/2005CA2561914A1 Microfluidized oil-in-water emulsions and vaccine compositions
10/20/2005CA2561686A1 Humanized anti-tgf-beta antibodies
10/20/2005CA2561276A1 Irta-5 antibodies and their uses
10/20/2005CA2561164A1 Steroid sparing agents and their use
10/20/2005CA2561163A1 Stabilised tat antigen and the use thereof for anti-hiv vaccination
10/20/2005CA2560941A1 Compositions as adjuvants to improve immune responses to vaccines and methods of use
10/20/2005CA2560937A1 Compositions and methods for inducing anti-tumor immunity
10/20/2005CA2560416A1 Angiogenesis-affecting compounds and methods of use thereof
10/20/2005CA2559910A1 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy
10/20/2005CA2558829A1 Methods for treating viral infection using il-28 and il-29 cysteine mutants
10/20/2005CA2555390A1 Immunostimulatory viral rna oligonucleotides
10/19/2005EP1586646A2 Lawsonia intracellularis vaccine
10/19/2005EP1586642A2 Tumor supressor genes, proteins encoded thereby and use of said genes and proteins
10/19/2005EP1586641A2 Compounds for the treatment of hypercalcemia and hypocalcemia
10/19/2005EP1586635A1 Fusion proteins with parts of immunoglobulins, their production and use
10/19/2005EP1586586A2 Peptide and/or proteins and their use for the manufacture of a therapeutic and/or preventive medicament
10/19/2005EP1586331A1 Development of a preventive vaccine for filovirus infection in primates
10/19/2005EP1586330A1 Vaccination against malignant melanoma
10/19/2005EP1586329A1 Botulinum toxin pharmaceutical compositions
10/19/2005EP1586284A1 Induction of immunological tolerance
10/19/2005EP1585966A2 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES
10/19/2005EP1585769A2 Neuropilin-1 inhibitors
10/19/2005EP1585547A2 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents
10/19/2005EP1585546A2 Kim-1 antagonists and use to modulate immune system
10/19/2005EP1585545A2 Methods of inducing and maintaining immune tolerance
10/19/2005EP1585544A1 Nematode polypeptide adjuvant
10/19/2005EP1585543A1 Treatment of autoimmune diseases using an activator for the notch signaling pathway
10/19/2005EP1585542A2 Immunogenic compositions containing phospholipid
10/19/2005EP1585535A2 Pthrp-derived modulators of smooth muscle proliferation
10/19/2005EP1354054B1 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/19/2005EP1353948B1 Soluble cyclic analogues of the beta amyloide peptide
10/19/2005EP1259251B1 Novel method for down-regulation of amyloid
10/19/2005EP1152061B1 Method for screening physiologically active pyrrole imidazole derivative
10/19/2005EP1109570B1 Modulation of memory effector t-cells with a cd2 binding agent
10/19/2005EP1061905B1 Compositions for detection and diagnosis of infectious mycobacterial diseases
10/19/2005EP1002054B1 Process for the production of virus in cell cultures
10/19/2005EP1000163B1 Pseudomonas exotoxin a-like chimeric immunogens
10/19/2005EP0918539B1 Vaccine for b-cell malignancies
10/19/2005EP0882132B1 A human cytomegalovirus combined antigen and its use
10/19/2005EP0846173B1 Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma
10/19/2005EP0771208B1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
10/19/2005EP0768894B1 Multi-stage cascade boosting vaccine
10/19/2005CN1685064A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/19/2005CN1685039A Secreted acid phosphatase (SAPM) is present only in pathogenic mycobacteria and expressed selectively at phagosomal PH
10/19/2005CN1684977A Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
10/19/2005CN1684708A Anti-NGF antibodies for the treatment of various disorders
10/19/2005CN1684707A Mucosal combination vaccines for bacterial meningitis
10/19/2005CN1683405A Clonorichis sinensis II 14-3-3 protein, its coded nucleic acid and its use
10/19/2005CN1683404A Clonorichis sinensis ubiquitin homogenetic protein, its coded nucleic acid and its use
10/19/2005CN1683403A Japanese blood fluke cell periodic static agent, its coded nucleic acid and its use
10/19/2005CN1683402A Clonorichis sinensis annexin, its coded nucleic acid and its use
10/19/2005CN1683401A Clonorchis sinensis GTP bindin alpha subunit, its coded nucleic acid and its use
10/19/2005CN1683012A Ginsenoside nano microparticle and its preparing method and use
10/19/2005CN1683011A Human vaccine containing bee glue adjuvent and its preparing method
10/19/2005CN1683010A Human papillomavirus type bivalent virus-like particle mixed protein antigen and construction method
10/19/2005CN1683009A Specific skin regent for diagnozing tuberculomyces infection and active tuberculosis
10/19/2005CN1682682A Hair tension and hardness improving agent
10/19/2005CN1223682C Diagnose test
10/19/2005CN1223608C Caspase-8 interacting proteins
10/19/2005CN1223605C Polypeptide medicine for inhibiting SARS corona virus, and derivatives and use thereof
10/19/2005CN1223377C Selection and production of inactivated vaccine Lu 8 line of hepatitis A
10/19/2005CN1223376C Polyepitope hepatitis C antigen complex polypeptide vaccine and its prepn and application
10/19/2005CN1223375C Heat resisting lyophilized protectant for chicken infectious bronchitis H120, H52, Kidney infectious bronchitis W93 lyophilized vaccine and preparing process thereof
10/18/2005US6956110 Genes involved in the molecular paths of tumor suppression and/or resistance to viruses
10/18/2005US6956105 Chandra: a Th1-specific protein
10/18/2005US6956051 amphiphilic drug-oligomer conjugates comprising a therapeutic compound conjugated to an oligomer, wherein the oligomer comprises a lipophilic moiety coupled to a hydrophilic moiety; therapeutic agents coupled to amphiphilic oligomers
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955883 Life sciences business systems and methods
10/18/2005US6955873 kit comprises buccal swab for obtaining DNA sample for allelic analysis; comprises signal transmitter precursor, enhancer of precursor uptake, and inhibitor of neurotransmitter reuptake/signal transmitter catabolism; attention deficit disorder
10/18/2005US6955818 for control of an external parasite on an animal of agricultural worth comprising 0.1 to 40% by weight of at least one spinosyn, and a non-irritant topically acceptable carrier, for example, tripropylene glycol methyl ether and benzyl alcohol
10/18/2005US6955813 Therapy for injured muscles
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005CA2033640C Vaccines against cancer and infectious diseases
10/13/2005WO2005095975A2 Anti-fungal target genes
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095598A1 Cancer antigen peptide originating in wt1
10/13/2005WO2005095460A2 Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof
10/13/2005WO2005095459A2 Monoclonal antibodies to gastrin hormone
10/13/2005WO2005095458A1 CHIMERIC MONOCLONAL ANTIBODY FOR BINDING WITH HIGH AFFINITY SELECTIVELY TO hCG
10/13/2005WO2005095457A2 Immunoglobulins
10/13/2005WO2005095456A1 An gene enginf; ering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody
10/13/2005WO2005095454A1 Lng105 antibody composition and methods of use, and use of lng105 to assess lung cancer risk
10/13/2005WO2005095442A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
10/13/2005WO2005094900A1 Preventive and/or remedy for cancer
10/13/2005WO2005094886A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor
10/13/2005WO2005094883A2 Methods for inducing autolysis in infectious bacteria
10/13/2005WO2005094882A1 Modified antibodies to prostate-specific membrane antigen and uses thereof
10/13/2005WO2005094881A1 Antibody drug
10/13/2005WO2005094880A1 Method for treating autoimmune diseases with antibodies
10/13/2005WO2005094878A1 Composition having antitumor effect
10/13/2005WO2005094877A2 Formulation of glutamic acid decarboxylase (gad65) and serum albumin
10/13/2005WO2005094876A1 Diagnostics and therapeutics for diseases associated with p21 (cdkn1a)-activated kinase 2 (pak2)
10/13/2005WO2005094863A1 Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and decting protease inhibitors
10/13/2005WO2005094846A1 Remedy for prion disease and method of producing the same
10/13/2005WO2005094785A2 Compositions capable of facilitating penetration across a biological barrier
10/13/2005WO2005094533A2 Trail-r as a negative regulator of innate immune cell responses
10/13/2005WO2005094446A2 Anti-myostatin antibodies
10/13/2005WO2005094415A2 Recombinant vectors and methods for inducing an immune response
1 ... 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 ... 1823